Nonnegative principal component analysis for mass spectral serum profiles and biomarker discovery.
BACKGROUND
As a novel cancer diagnostic paradigm, mass spectroscopic serum proteomic pattern diagnostics was reported superior to the conventional serologic cancer biomarkers. However, its clinical use is not fully validated yet. An important factor to prevent this young technology to become a mainstream cancer diagnostic paradigm is that robustly identifying cancer molecular patterns from high-dimensional protein expression data is still a challenge in machine learning and oncology research. As a well-established dimension reduction technique, PCA is widely integrated in pattern recognition analysis to discover cancer molecular patterns. However, its global feature selection mechanism prevents it from capturing local features. This may lead to difficulty in achieving high-performance proteomic pattern discovery, because only features interpreting global data behavior are used to train a learning machine.


METHODS
In this study, we develop a nonnegative principal component analysis algorithm and present a nonnegative principal component analysis based support vector machine algorithm with sparse coding to conduct a high-performance proteomic pattern classification. Moreover, we also propose a nonnegative principal component analysis based filter-wrapper biomarker capturing algorithm for mass spectral serum profiles.


RESULTS
We demonstrate the superiority of the proposed algorithm by comparison with six peer algorithms on four benchmark datasets. Moreover, we illustrate that nonnegative principal component analysis can be effectively used to capture meaningful biomarkers.


CONCLUSIONS
Our analysis suggests that nonnegative principal component analysis effectively conduct local feature selection for mass spectral profiles and contribute to improving sensitivities and specificities in the following classification, and meaningful biomarker discovery.
Han
Henry
H
Department of Mathematics and Bioinformatics, Eastern Michigan University, Ypsilanti, MI 48109, USA. henry.ahan@gmail.com
D000465:Algorithms; D001185:Artificial Intelligence; D015415:Biomarkers / Q000032:analysis / Q000097:blood*; D013058:Mass Spectrometry / Q000379:methods*; D025341:Principal Component Analysis; D020543:Proteome / Q000032:analysis / Q000145:classification; D040901:Proteomics / Q000379:methods*
D015415:Biomarkers; D020543:Proteome